With a membership of more than 2,000 researchers and others interested in HIV research, the Canadian Association for HIV Research (CAHR) is the leading organization of HIV/AIDS researchers in Canada. As an integral element of its mandate, CAHR works to “promote education and the development of researchers” and “engage diverse stakeholders in ongoing dialogue and knowledge exchange”. As part of this effort, and with the generous support of ViiV Healthcare, CAHR will be offering travel awards for Canadian health care professionals (HCPs) – working in the realm of HIV – to attend international continuing health education events.


Click on the links below to go directly to any of the following sections:



Via this funding competition, CAHR’s will fund travel award applications for eligible HCP to attend each of the following international continuing health education events:





# of Awards

Application Deadline

Notice of Decision

Conference of Retroviruses and Opportunistic Infections (CROI) 10 Closed  Results
European Meeting on HIV & Hepatitis (May 30-June 1) 2 Feb 16, 2018 Feb 26, 2018
HIV & Hep C Clinical Pharmacology Workshop (May 22-24) 2 March 9, 2018 March 19, 2018
World AIDS (July 23-27) 10 March 30, 2018 April 9, 2018
ID Week (October 3-7) 4 June 22, 2018 July 3, 2018
Glasgow (October 28-31) 10 June 29, 2018 July 17, 2018
Association of Nurses in AIDS Care (ANAC) 4 July 27, 2018 August 7, 2018



The following expenditures are eligible for funding:

  1. Travel – Depending on the location of the event and your home city, travel may be by air, train or bus. Mileage is not funded.
  2. Accommodation – The hotel room rate and taxes are funded for the duration of the event.
  3. Registration – Only the event registration fee is funded. Additional items such as workshops, gala events and tours are not eligible for funding.

In all cases, NO funding will be provided directly to the awardee or his/her institution. CAHR will arrange payment of awardee travel, accommodation and registration to the international continuing health education event. Costs involving extensions, cancellations and/or changes are at the awardee’s expense.



  • Applicants must be a Canadian citizen or a permanent resident of Canada
  • Applicants must be an active Canadian health care professional (HCP) working in the realm of HIV. For the purpose of this funding opportunity, HCP is defined as a person who by education, training, certification, or licensure is qualified to and is engaged in providing health care. This can include any of the following: an individual who is currently practicing medicine or dispensing medicines in Canada.
  • Nurses are solely eligible for the Association of Nurses in AIDS Care (ANAC) Conference but are not eligible for the remaining events
  • NOTE: For CROI, applicant must demonstrate that CROI has accepted their registration or registration fee will not be reimbursed.
  • CAHR board members, government officials, and HCPs with active U.S. medical licenses are not eligible.


A complete application must include:

  • A maximum two-page letter, using no more than 1000 words, that:
    • Summarizes the applicant’s relevant experience/training
    • Demonstrates that the applicant meets the eligibility requirements
    • Describes how the applicant meets the evaluation criteria
    • Outlines how the applicant will fulfill the communications requirements
  • The applicant’s CV
  • Proof of Canadian citizen or a permanent residency of Canada
  • Proof of HCP status in Canada
  • Declaration that applicant is neither a US medical license holder or Government official


CAHR encourages applicants to submit proposals in the Official Language of their choice and commits to ensuring high quality review of applications submitted in either Official Language.



Successful candidates must:

  • Confirm that they have not already received funding from another funding body to attend the same conference
  • Accept their award within 5 working days of the date of offer or the award will be cancelled and offered to the next fundable applicant
  • Not have held an award for the same event in 2016

Funding is non-renewable. Individuals may only hold one award per calendar year and are not eligible to hold awards for the same event in sequential years.


Award recipients must

  • Agree to share the benefits of knowledge gained through the event with other Canadian HCPs by either (a) submitting a written report for publication to a specialty society or academic institution, or (b) giving a verbal presentation to HCPs in an appropriate venue
  • Acknowledge CAHR/ViiV financial support in any report/presentation related to the event



Recipients will be asked to provide a one-page End of Award report within two months of termination of the award. Details regarding this report will be communicated to the recipients when the funds are released. Failure to submit the End of Award report will render the HCP ineligible for future funding.


CAHR will assemble an independent review committee comprised of peers to adjudicate the applications.


The priority areas for adjudication are:

  • Demonstration that the HCP has the requisite training and expertise as appropriate for the subject matter of the event
  • Demonstration that the HCP can show benefits to their HIV patients from attending
  • Demonstration that the HCP will be participating in the conference as a presenter or has other active participation in original research or scientific work that is being presented (e.g. abstract submission)
  • Demonstration that the HCP will share the knowledge gained with a larger community after the conference because they teach in colleges or postgraduate units, or are part of a larger network of HCPs anticipating feedback from the conference


Upon completion of peer review, CAHR will generate the ranking list, ratings and funding recommendations. The list will be used for funding decision-making purposes and will remain anonymous.

Applications will be funded from the top down in order of ranking as far as the budget will allow. Applications that receive a rating below 3.5 will not be funded (rating scale is 0-5).



2018 Results

2017 Results

2016 Results



Please contact hcpawards@cahr-acrv.ca for more information.


ViiVHealthcare ULC

ViiV Healthcare in Canada, a company devoted to HIV/AIDS research and treatment and to supporting people affected by HIV/AIDS across Canada. ViiV Healthcare in Canada is part of ViiV Healthcare, a global specialist HIV company established by GSK and Pfizer in 2009 and joined by Shionogi in 2012. We are committed to taking a deeper and broader interest in HIV/AIDS than any other pharmaceutical company has done before. We have advanced research and development and also work in partnership with HIV/AIDS communities across Canada: populations at risk, people living with HIV/AIDS, their caregivers and support organizations, and healthcare providers. ViiV Healthcare’s Canadian operations are headquartered in Laval, Quebec. For further information on ViiV Healthcare, please visit www.viivhealthcare.ca